Integer Holdings Corporation

Valuation Analysis

About the Company

Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; implanted medical devices, implanted leads, procedure accessories, and external devices; neuromodulati

Integer Holdings Corporation Stock at a Glance

Integer Holdings Corporation (ITGR) is currently trading at $90.98 with a market capitalization of $3.1B. The trailing P/E ratio stands at 22.58x, with a forward P/E of 13.36x. The 52-week range spans from $62.00 to $123.78; the current price is 26.5% below the yearly high. Year-over-year revenue growth stands at +0.5%. The net profit margin stands at 7.64%.

💰 Dividend

Integer Holdings Corporation currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

9 analysts rate Integer Holdings Corporation (ITGR) on consensus: None. The average price target is $97.56, implying +7.23% from the current price. Analyst price targets range from $84.00 to $115.00.

Integer Holdings Corporation: The Investment Case in Detail

Integer Holdings Corporation (ITGR) operates in the Healthcare — specifically Medical Devices — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bear Case

Revenue growth has slowed to just 0.5%, which is below nominal GDP — the business is no longer outgrowing the broader economy. Short interest sits at 16.05% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

What to Watch Next

• The forward P/E of 13.36x is meaningfully below the trailing 22.58x — analysts expect earnings to step up; the next earnings release is the test.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to relatively defensive market behavior, elevated short interest (16.05%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Integer Holdings Corporation?

Compare top-rated brokers — low fees, trusted providers, fully regulated.